Flash and pattern visual evoked potentials in the diagnosis and monitoring of dysthyroid optic neuropathy.
Flash and pattern visual evoked potentials were recorded in 8 patients (13 eyes) with dysthyroid optic neuropathy (DON), diagnosed using the American Thyroid Association classification. All were treated with systemic steroids, but 4 patients (6 eyes) also required orbital decompression. Flash VEP (P2) and pattern VEP (P100) were recorded prior to and 2 weeks after commencing steroid treatment or decompression. Fifteen patients with Graves orbitopathy but without DON, and 20 healthy subjects, acted as controls. Before treatment visual acuity was reduced in 10 eyes and visual fields were abnormal in 5, but the VEP was abnormal in all 13, with the group mean amplitude of P2 and P100 significantly less than controls, and the group mean P100 latency significantly greater than controls. After treatment with high-dose steroids or surgical decompression there were significant improvements in the group mean amplitude of P2 and P100, and significant reductions in P2 and P100 latency; however, individually, improvements in amplitude were more significant than improvements in latency. We conclude that the VEP to flash and pattern stimuli provides a useful diagnostic and monitoring tool in patients with DON, combining objectivity with quantitative analysis.
Tsaloumas
M D
MD
Visual Function Department, Birmingham and Midland Eye Hospital, UK.
Good
P A
PA
Burdon
M A
MA
Misson
G P
GP
D000328:Adult; D000368:Aged; D005074:Evoked Potentials, Visual / Q000502:physiology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009901:Optic Nerve Diseases / Q000175:diagnosis* / Q000209:etiology / Q000601:surgery; D010364:Pattern Recognition, Visual / Q000502:physiology; D010775:Photic Stimulation; D011239:Prednisolone / Q000008:administration & dosage; D013959:Thyroid Diseases / Q000150:complications*; D014792:Visual Acuity
D011239:Prednisolone